# Solve FSHD

Solve FSHD is a Venture Philanthropy based in Vancouver, Canada.

## Overview

- **Organization type:** Venture Philanthropy
- **Headquarters:** Vancouver, Canada
- **Region:** North America
- **Address:** Vancouver, British Columbia, Canada
- **Founded:** 2021
- **Assets under management:** $100M (firm disclosure)
- **Website:** solvefshd.com
- **LinkedIn:** https://www.linkedin.com/company/solve-fshd

## Regulatory record

- **Reports private funds:** No

## About

The future of genetic medicine is epic. | Epicrispr Biotechnologies is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI.

## Sectors

- Biotech
- Rare Disease Therapeutics

## People

- Chip Wilson — Founder & Chairman of the Board
- Neil Camarta — Board Member and Co-Founder
- Eva R. Chin — Executive Director

## Questions

### Who runs investment decisions at Solve FSHD?

Executive Director Eva R. Chin leads the management team and day-to-day operations, including grant and partnership selection. Scientific decisions are guided by a Scientific Advisory Board of FSHD experts, and the Board of Directors — chaired by Chip Wilson — provides strategic oversight. No external investment committee is involved; capital is deployed directly through the organization's grant and collaboration structure.

### Does Solve FSHD participate in fund commitments or only direct deals?

Solve FSHD makes direct grants and enters into strategic collaborations — it does not commit to external investment funds. Its model is analogous to a venture investor, but it funds research and development directly through partnerships with academic labs, biotech companies, and clinical trial sites. The Modalis collaboration is an example of an R&D partnership, not a financial investment.

### Which sectors does Solve FSHD explicitly avoid?

Solve FSHD only funds research and development directly related to FSHD — it avoids all other therapeutic areas and asset classes. The organization does not invest in real estate, public equities, venture capital funds, or non-FSHD biotech. Its entire mandate is focused on curing facioscapulohumeral muscular dystrophy.

## Related profiles

- [Atria Wealth Solutions](https://altss.com/profile/atria-wealth-solutions)
- [Brothers International Food](https://altss.com/profile/brothers-international-food)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/solve-fshd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology